KNG Health supports pharmaceutical and medical device companies’ efforts to obtain New Technology Add-on Payments (NTAP) under the Inpatient Prospective Payment System (IPPS). We have successfully performed high quality analysis to satisfy the cost criterion for a number of NTAP applicants. Our work covers the development of relevant patient cohorts, claims data analyses, drafting of sections of the NTAP application, and briefing officials at the Centers for Medicare & Medicaid Services.
Back to Expertise